• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

ZEG Berlin GmbH

Zentrum für Epidemiologie und Gesundheitsforschung

  • Home
  • Expertise
    • Real-World Evidence
    • Non-interventional study design
    • Post-authorization safety studies
    • Post-authorization efficacy studies
    • Cohort studies
    • Case-control studies
    • Medical Devices
    • Diagnostic tools
      • Research team
    • Data collection instruments
  • Services
    • RWE Services
    • Crisis Management
    • Consulting
    • Data Management and Biostatistics
    • Medical Writing
    • Study Management
    • Quality Assurance
    • Pharmacovigilance
  • Library & News
    • News/Conferences
    • Publications
  • About Us
    • Who We Are
      • Management Board
      • Executive Team
      • Project Management Team
    • History
    • Careers
    • Data Protection Information
  • Contact

Elena Garal-Pantaler

  • share 
  • tweet 
  • share 
  • share 

Publications

Ding Bo, Pignot Marc, Garal-Pantaler Elena, Villinger Beate, Desta Barnabas, Schmidt Katharina, Golam Sarowar, Stirnadel-Farrant Heide, Schwarting Andreas, Clinical Characteristics, Health Care Resource Utilization, and Costs Associated With Flares in Patients With Systemic Lupus Erythematosus in Germany Ann. Rheum. Dis. - EULAR 2022 Annual European Congress of Rheumatology, June 1–4. 2022;
N Hunnicutt Jake, Schultze Michael, Garal-Pantaler Elena, Pignot Marc, Georgiou Mary Elizabeth, Gairy Kerry, Prevalence of lupus nephritis among patients with systemic lupus erythematosus in Germany Nephrology Dialysis Transplantation, Volume 37, Issue Supplement_3, May. 2022; 10.1093/ndt/gfac071.036.
Ding Bo, Pignot Marc, Garal-Pantaler Elena, Villinger Beate, Desta Barnabas, Golam Sarowar, Stirnadel-Farrant Heide, Marinoska Tatjana, Schefzyk Sebastian, Schwarting Andreas, Corticosteroid Use in Patients With Systemic Lupus Erythematosus in Germany: The CHAMOMILE Claims Database Study. DGRh 2022, Berlin, Germany 31 August–3 September. 2022;
Schultze Michael, Garal-Pantaler Elena, Pignot Marc, Carnarius H., Gairy Kerry, Levy R., Economic Burden of Organ Damage in Systemic Lupus Erythematosus: Results From a German Claims Analysis. DGRh Kongress. 2021; 10.3205/21dgrh064.
Schultze Michael, Garal-Pantaler Elena, Pignot Marc, Carnarius H., Levy R., Gairy Kerry, The Burden of Organ Damage Among Patients With Systemic Lupus Erythematosus in Germany. International Congress on Systemic Lupus Erythematosus. LUPUS & CORA 2021. 2021;
Schwarting Andreas, Friedel H., Garal-Pantaler Elena, Pignot Marc, Wang X., Nab H., Desta Barnabas, Hammond E. R., The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization. Rheumatol Ther.. 2021; 10.1007/s40744-021-00277-0.
Birkeland Kåre I., Bodegard Johan, Eriksson Jan W., Norhammar Anna, Haller Hermann, Linssen Gerard C. M., Banerjee Amitava, Thuresson Marcus, Okami Suguru, Garal-Pantaler Elena, Overbeek Jetty, Mamza Jil Billy, Zhang Ruiqi, Yajima Toshitaka, Komuro Issei, Kadowaki Takashi, Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study. Diabetes Obes Metab.. 2020; 22:1607–1618. 10.1111/dom.14074.
Birkeland Kåre I., Bodegard Johan, Eriksson Jan W., Norhammar Anna, Haller Hermann, Linssen Gerard C. M., Banerjee Amitava, Thuresson Marcus, Okami Suguru, Garal-Pantaler Elena, Overbeek Jetty, Mamza Jil Billy, Zhang Ruiqi, Yajima Toshitaka, Komuro Issei, Kadowaki Takashi, Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study. Diabetes Obes Metab.. 2020; 22:1607–1618. 10.1111/dom.14074.
Birkeland Kåre I., Bodegard Johan, Eriksson Jan W., Norhammar Anna, Thuresson Marcus, Pignot Marc, Garal-Pantaler Elena, Yajima Toshitaka, Komuro Issei, Kadowaki Takashi, Cardiorenal disease is the most common first CV manifestation in type 2 diabetes and associated with increased mortality: a large multinational observational study EASD Congress. 2019;
Birkeland Kåre I., Bodegard Johan, Eriksson Jan W., Norhammar Anna, Thuresson Marcus, Pignot Marc, Garal-Pantaler Elena, Yajima Toshitaka, Komuro Issei, Kadowaki Takashi, Cardiorenal disease is the most common first CV manifestation in type 2 diabetes and associated with increased mortality: a large multinational observational study European Association for the Study of Diabetes 55th Annual Meeting. 2019;
Schwarting Andreas, Friedel H., Garal-Pantaler Elena, Pignot Marc, Wang X., Nab H., Desta Barnabas, Hammond E. R., The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization. Rheumatol Ther. 2018; 10.1007/s40744-021-00277-0.
Hammond E. R., Friedel H., Garal-Pantaler Elena, Pignot Marc, Velthuis E., Wang X., Nab H., Desta Barnabas, Schwarting Andreas, Health Care Resource Use (HRU) and Medical Costs Analyses as a Function of Systemic Lupus Erythematosus (SLE) Disease Severity: Analysis of Claims Data of a German Sickness Fund. LUPUS. 2018; 5(Suppl 1): A1–A129. 10.1136/lupus-2018-abstract.204.
Hammond E. R., Friedel H., Garal-Pantaler Elena, Pignot Marc, Velthuis E., Wang X., Nab H., Desta Barnabas, Schwarting Andreas, Health Care Resource Utilisation (HCRU) and Cost Analyses of Systemic Lupus Erythematosus (SLE) as a Function of Disease Severity: Analysis of Real-World Claims Data from a German Sickness Fund. Ann. Rheum. Dis. 2018; 10.1136/annrheumdis-2018-eular.5150.

sidebar

Executive Team

  • Clare Barnett
  • Karl Pauls
  • Michael Schultze
  • Alfred Pauls
  • Anja Bauerfeind
  • Do Minh Thai
  • Elisabeth Finger
  • Jens A. Lange

Management Board

  • Klaas Heinemann
  • Clare Barnett
  • Marc Pignot
  • Karl Pauls
  • Johanna Poppe

Project Management Team

  • Pauline De Corte
  • Lisa Eggebrecht
  • Maria Cabral
  • Anitha Pitchika
  • Mohammed Dagher

Search

sidebar-alt

Footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Invalidenstraße 115
10115 Berlin
Germany

Contact Us

Expertise

  • Real-World Evidence
  • Non-interventional study design
  • Post-authorization safety studies
  • Post-authorization efficacy studies
  • Cohort studies
  • Case-control studies
  • Medical Devices
  • Diagnostic tools
  • Data collection instruments

Services

  • Crisis Management
  • Consulting
  • Data Management and Biostatistics
  • Medical Writing
  • Study Management
  • Quality Assurance
  • Pharmacovigilance

ENCePP

We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

General Data Protection Regulation

With a view to the introduction of the GDPR/EUDSGVO we are glad to present our newupdated privacy policy . The updated description are stored under “about us” and then “privacy policy/GDPR”. Further translation for study participants will follow contemporary.

© 2011–2023 ZEG Berlin

Impressum

Website by Laura Yeffeth.